Regulation of nucleocytoplasmic shuttling of bruton's tyrosine kinase (Btk) through a novel sh3-dependent interaction with ankyrin repeat domain 54 (ANKRD54)

Molecular and Cellular Biology

Volumn 32, Issue 13, 2012, Pages 2440-2453

  Gustafsson, Manuela ^a   Hussain, Alamdar ^a   Mohammad, Dara K ^a   Mohamed, Abdalla J ^a,b   Nguyen, Vivian ^c   Metalnikov, Pavel ^c,f   Colwill, Karen ^c   Pawson, Tony ^c,d   Smith, C I Edvard ^a   Nore, Beston F ^a,e  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITI BRUNEI DARUSSALAM   (Brunei Darussalam)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e UNIVERSITY OF SULAIMANI   (Iraq)

^f All Russian Center on Quality and Standardization of Veterinary Medications and Feed   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ANKYRIN REPEAT DOMAIN 54 PROTEIN; BINDING PROTEIN; BRUTON TYROSINE KINASE; EXPORTIN 1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; SEQUENCE ANALYSIS; SH3 DOMAIN;

ACTIVE TRANSPORT, CELL NUCLEUS; AMINO ACID SEQUENCE; ANIMALS; ANKYRIN REPEAT; BASE SEQUENCE; CARRIER PROTEINS; CELL LINE; CERCOPITHECUS AETHIOPS; COS CELLS; HEK293 CELLS; HUMANS; JURKAT CELLS; K562 CELLS; MICE; MODELS, BIOLOGICAL; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PROTEIN INTERACTION MAPPING; PROTEIN-TYROSINE KINASES; RATS; RECOMBINANT FUSION PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID; SRC HOMOLOGY DOMAINS;

MURINAE;

EID: 84864007257     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.06620-11     Document Type: Article

References (48)

1. Afar DE, et al. 1996. Regulation of Btk by Src family tyrosine kinases. Mol. Cell. Biol. 16:3465-3471.
2. Aints A, Belusa R, Andersson RM, Guven H, Dilber MS. 2002. Enhanced ouabain resistance gene as a eukaryotic selection marker. Hum. Gene Ther. 13:969 -977.
3. Bäckesjö CM, Vargas L, Superti-Furga G, Smith CIE. 2002. Phosphorylation of Bruton's tyrosine kinase by c-Abl. Biochem. Biophys. Res. Commun. 299:510 -515.
4. Barrick D, Ferreiro DU, Komives EA. 2008. Folding landscapes of ankyrin repeat proteins: experiments meet theory. Curr. Opin. Struct. Biol. 18:27-34.
5. Chen GI, Gingras AC. 2007. Affinity-purification mass spectrometry (AP-MS) of serine/threonine phosphatases. Methods 42:298 -305.
6. Debnath J, et al. 1999. rlk/TXK encodes two forms of a novel cysteine string tyrosine kinase activated by Src family kinases. Mol. Cell. Biol. 19: 1498-1507.
7. Gomez-Rodriguez J, et al. 2007. Tec kinases, actin, and cell adhesion. Immunol. Rev. 218:45- 64.
8. Halcomb KE, Musuka S, Gutierrez T, Wright HL, Satterthwaite AB. 2008. Btk regulates localization, in vivo activation, and class switching of anti-DNA B cells. Mol. Immunol. 46:233-241.
9. Hamada N, Backesjo CM, Smith CI, Yamamoto D. 2005. Functional replacement of Drosophila Btk29A with human Btk in male genital development and survival. FEBS Lett. 579:4131- 4137.
10. Hansson H, et al. 1998. Solution structure of the SH3 domain from Bruton's tyrosine kinase. Biochemistry 37:2912-2924.
11. Haskill S, et al. 1991. Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity. Cell 65:1281-1289.
12. Hunter T. 2000. Signaling-2000 and beyond. Cell 100:113-127.
13. Hyvonen M, Saraste M. 1997. Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: molecular explanations for X-linked agammaglobulinaemia. EMBO J. 16:3396 -3404.
14. Israel A. 2000. The IKK complex: an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10:129 -133.
15. King CC, Sastri M, Chang P, Pennypacker J, Taylor SS. 2011. The rate of NF-kappaB nuclear translocation is regulated by PKA and A kinase interacting protein 1. PLoS One 6:e18713.
16. Kurosaki T, Hikida M. 2009. Tyrosine kinases and their substrates in B lymphocytes. Immunol. Rev. 228:132-148.
17. Li J, Mahajan A, Tsai MD. 2006. Ankyrin repeat: a unique motif mediating protein-protein interactions. Biochemistry 45:15168 -15178.
18. Li T, et al. 1995. Activation of Bruton's tyrosine kinase (BTK) by a point mutation in its pleckstrin homology (PH) domain. Immunity 2:451- 460.
19. Lindvall JM, et al. 2005. Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling. Immunol. Rev. 203:200 -215.
20. Liu X, Pawson T. 1994. Biochemistry of the Src protein-tyrosine kinase: regulation by SH2 and SH3 domains. Recent Prog. Horm. Res. 49:149- 160.
21. Manning G, Plowman GD, Hunter T, Sudarsanam S. 2002. Evolution of protein kinase signaling from yeast to man. Trends Biochem. Sci. 27:514- 520.
22. McClintock TS, Glasser CE, Bose SC, Bergman DA. 2008. Tissue expression patterns identify mouse cilia genes. Physiol. Genomics 32:198- 206.
23. Mihara S, Suzuki N. 2007. Role of Txk, a member of the Tec family of tyrosine kinases, in immune-inflammatory diseases. Int. Rev. Immunol. 26:333-348.
24. Miller AT, Wilcox HM, Lai Z, Berg LJ. 2004. Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 21:67- 80.
25. Mohamed AJ, et al. 2000. Nucleocytoplasmic shuttling of Bruton's tyrosine kinase. J. Biol. Chem. 275:40614-40619.
26. Mohamed AJ, et al. 2009. Bruton's tyrosine kinase (Btk): function, regulation, and transformation with special emphasis on the PH domain. Immunol. Rev. 228:58 -73.
27. Mosavi LK, Cammett TJ, Desrosiers DC, Peng ZY. 2004. The ankyrin repeat as molecular architecture for protein recognition. Protein Sci. 13: 1435-1448.
28. Mosavi LK, Minor DL, Jr, Peng ZY. 2002. Consensus-derived structural determinants of the ankyrin repeat motif. Proc. Natl. Acad. Sci. U. S. A. 99:16029 -16034.
29. Nore BF, et al. 2000. Redistribution of Bruton's tyrosine kinase by activation of phosphatidylinositol 3-kinase and Rho-family GTPases. Eur. J. Immunol. 30:145-154.
30. Ortutay C, Nore BF, Vihinen M, Smith CI. 2008. Phylogeny of Tec family kinases identification of a premetazoan origin of Btk, Bmx, Itk, Tec, Txk, and the Btk regulator SH3BP5. Adv. Genet. 64:51- 80.
31. Park H, et al. 1996. Regulation of Btk function by a major autophosphorylation site within the SH3 domain. Immunity 4:515-525.
32. Pawson T, Scott JD. 2005. Protein phosphorylation in signaling-50 years and counting. Trends Biochem. Sci. 30:286 -290.
33. Perez-Villar JJ, O'Day K, Hewgill DH, Nadler SG, Kanner SB. 2001. Nuclear localization of the tyrosine kinase Itk and interaction of its SH3 domain with karyopherin alpha (Rch1alpha). Int. Immunol. 13:1265- 1274.
34. Rawlings DJ, et al. 1993. Mutation of unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358 -361.
35. Rawlings DJ, et al. 1996. Activation of BTK by a phosphorylation mechanism initiated by SRC family kinases. Science 271:822- 825.
36. Readinger JA, Mueller KL, Venegas AM, Horai R, Schwartzberg PL. 2009. Tec kinases regulate T-lymphocyte development and function: new insights into the roles of Itk and Rlk/Txk. Immunol. Rev. 228:93-114.
37. Sachdev S, Hoffmann A, Hannink M. 1998. Nuclear localization of IkappaB alpha is mediated by the second ankyrin repeat: the IkappaB alpha ankyrin repeats define a novel class of cis-acting nuclear import sequences. Mol. Cell. Biol. 18:2524 -2534.
38. Saito K, et al. 2003. BTK regulates PtdIns-4,5-P2 synthesis: importance for calcium signaling and PI3K activity. Immunity 19:669-678.
39. Samuels AL, Klinken SP, Ingley E. 2009. Liar, a novel Lyn-binding nuclear/cytoplasmic shuttling protein that influences erythropoietininduced differentiation. Blood 113:3845-3856.
40. Schmidt EE, Ichimura K, Messerle KR, Goike HM, Collins VP. 1997. Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. Br. J. Cancer 75:2- 8.
41. Smith CI, et al. 2001. The Tec family of cytoplasmic tyrosine kinases: mammalian Btk, Bmx, Itk, Tec, Txk and homologs in other species. Bioessays 23:436-446.
42. Taagepera S, et al. 1998. Nuclear-cytoplasmic shuttling of C-ABL tyrosine kinase. Proc. Natl. Acad. Sci. U. S. A. 95:7457-7462.
43. Thomas JD, et al. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-358.
44. Tsukada S, et al. 1993. Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72:279 -290.
45. Vetrie D, et al. 1993. The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases. Nature 361:226 -233.
46. Vihinen M, et al. 1997. BTKbase, mutation database for X-linked agammaglobulinemia (XLA). Nucleic Acids Res. 25:166 -171.
47. Webb CF, et al. 2000. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165:6956-6965.
48. Yoshida K. 2008. Nuclear trafficking of proapoptotic kinases in response to DNA damage. Trends Mol. Med. 14:305-313.